Pressrelease1
Biophytis Announces Launch of aPublic Offering of Share Subscription Warrants (BSA) with an Irreducible Priority Subscription Period forExisting Shareholders Paris, (France), Cambridge (Massachusetts, United States), April 7, 2020, 8:00 a.m. CEST -Biophytis SA (Euronext Growth Paris: ALBPSa clinical-stage biotechnology company specialized in the development of drug candidates for treatment of aged related diseases, amongst which neuromuscular diseases, today announcesthe launch of a public offering, of 7,445,123 Share Subscription Warrants (BSA), at a unit price of €0.06 by way of a public offeringwith anirreducible priority subscription period for existing shareholders. The offer could be increased to7,475,708 BSA pursuant to anextension clause.BSA OfferingThe proposed issuanceof the 7,445,123 BSA, to be subscribed in cash, will be carried out with shareholders preferential right of subscription removed. The Offer will include (i) a priority period for shareholders onan irreducible basis only, with 3 BSA for 16 shares as ofApril 8, 2020 (rounded to the higher unit if the number of shares is not a multiple of 16) and (ii) an extensionclauseto increase the issue to 7,475,708 BSA.The subscription price will be 0.06 euro per BSA.Shareholders registered as of April 8, 2020 will benefit from a non-negotiable and non-transferable subscription priority period, from April 9, 2020 to April 21, 2020 included at 12:00 p.m. (Paris time). As part of the priority period, the Company's shareholders will be able to subscribe on an irreducible basis to the extent of their sharesin the Company's capitalpursuant to the parity here above. There are no plans to subscribe on a reducible basis as part of the priority period.Unsubscribed BSAs will then be offered as a priority to the Company's employees and executive officers within the limits of their requests. The Priority Period relates to the initial issuance amount, excluding the extension clause.The BSAs that remain unsubscribed followingthe above mentioned prioritiesincluding the Company's shareholders, employees and executive officers, will be part of a public offering (including the Company's shareholders in case of additional requests) open in France from April 9, 2020 to April 21, 2020 included,at 12pm(Paris time).The extension clause will allow the subscription of a maximum of 30,585 additional BSAat the offer price.The settlement-delivery of the BSA issueis scheduled for April 30, 2020. Newly issued BSAs will bear rights from that date